The NCI Board of Scientific Advisors unanimously approved six new concepts and two reissue concepts at a joint meeting of the BSA and the National Cancer Advisory Board.
In 1991, NCI recorded impact statements commemorating the twentieth anniversary of the National Cancer Act of 1971—and now this historic document has been digitized and made searchable in the Cancer History Project.
Monica Bertagnolli, the 16th director of the National Cancer Institute, announced that she will be undergoing treatment for early-stage breast cancer.
Within two months of stepping in as director of the Advanced Research Projects Agency for Health, Renee Wegrzyn has grown her staff fivefold, built a website, juggled 30 congressional meetings, and met with 10 patient advocacy organizations.
At the 2022 annual meeting of the Association of American Cancer Institutes—hosted by The University of Kansas, the newest NCI-designated Comprehensive Cancer Center—Dr. Doug Lowy, then acting NCI director, discussed how enhancing the way centers communicate research is vital to the eradication of cancer.
Pragmatica-Lung is shaping up as the clinical trial to watch—not just because of the research question, but because of the way it’s being addressed.
Pragmatica-Lung is the first of what is likely to be a series of simpler trials with relaxed enrollment criteria and streamlined data collection requirements.
The Pragmatica-Lung trial required many people to start to think differently about conducting phase III clinical trials—and it took a lot of advocacy to make the trial launch quickly, said Ellen Sigal, founder and chair of Friends of Cancer Research.
I read with interest the recently published story on the recommendations to streamline data collection in certain NCI trials presented at the Nov. 9, 2022, meeting of the Clinical and Translational Research Committee (The Cancer Letter, Nov. 11, 2022).
The NCI Clinical Trials and Translational Research Advisory Committee has approved an interim set of guidelines for streamlining requirements for conduct of clinical trials.